Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.0 is now shown in the page footer, replacing the previous label. The prior Revision: v3.4.3 label has been removed.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1, and the funding-status notice has been removed.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, indicating information may not be up to date and transactions may not be processed until appropriations are enacted, with guidance to check status on cc.nih.gov and opm.gov. Updated the page revision tag to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check70 days agoChange DetectedAdded UI/metadata items Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check105 days agoChange DetectedFooter updated to display Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL
Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.